title: Decreased cervicovaginal production of both IgA1 and IgA2 subclasses in women with AIDS.
abstract: Paired sera and cervicovaginal secretions from 35 HIV-1-infected women representing different CDC stages of HIV infection were evaluated for total IgA, IgA1 and IgA2, for IgA, IgA1 and IgA2 to gp160, and for albumin. Age-matched healthy women (n = 45) served as controls. The secretion rates of total IgA, IgA1 and IgA2 were evaluated by calculating their relative coefficients of excretion by reference to albumin. In HIV-infected women, total IgA1 and IgA2 in sera and in cervicovaginal secretions increased proportionately as early as stages II + III and more markedly at stage IV. By contrast, the secretion rates of total IgA IgA1 and IgA2 were markedly reduced in AIDS women, the IgA2 secretion rate decreasing significantly as early as stages II + III. This apparent discrepancy was probably the result of increased transudation of serum-borne immunoglobulins into the vaginal cavity, since albumin levels in cervicovaginal secretions increased significantly according to the stages of disease. HIV-reactive IgA antibodies in serum, as in cervicovaginal secretions, were principally found within the IgA1 subclass. In women at stage IV, a high local production of IgA1 to gp160 occurred in spite of the impairment of cervicovaginal IgA synthesis, probably because of marked genital HIV replication at advanced stages.
authors.affiliation: Unité d'Immunologie Microbienne, Institut Pasteur, Paris, France.
authors.forename: L
authors.initials: L
authors.lastname: Belec
authors.forename: D
authors.initials: D
authors.lastname: Meillet
authors.forename: O
authors.initials: O
authors.lastname: Gaillard
authors.forename: T
authors.initials: T
authors.lastname: Prazuck
authors.forename: E
authors.initials: E
authors.lastname: Michel
authors.forename: J
authors.initials: J
authors.lastname: Ngondi Ekome
authors.forename: J
authors.initials: J
authors.lastname: Pillot
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000378:metabolism*; D000293:Adolescent; D000328:Adult; D000918:Antibody Specificity; D002584:Cervix Uteri / Q000378:metabolism*; D005260:Female; D015686:Gene Products, env / Q000276:immunology; D019302:HIV Envelope Protein gp160; D006801:Humans; D007070:Immunoglobulin A / Q000096:biosynthesis* / Q000097:blood* / Q000276:immunology; D011498:Protein Precursors / Q000276:immunology; D012709:Serum Albumin / Q000032:analysis; D014621:Vagina / Q000378:metabolism*
chemical_list: D015686:Gene Products, env; D019302:HIV Envelope Protein gp160; D007070:Immunoglobulin A; D011498:Protein Precursors; D012709:Serum Albumin